Azitra, Inc. (NYSEAMERICAN:AZTR) Sees Significant Increase in Short Interest

Azitra, Inc. (NYSEAMERICAN:AZTRGet Free Report) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 435,300 shares, a growth of 247.1% from the May 31st total of 125,400 shares. Currently, 2.7% of the shares of the stock are short sold. Based on an average trading volume of 1,880,000 shares, the days-to-cover ratio is currently 0.2 days.

Azitra Stock Up 12.7 %

AZTR stock traded up $0.01 on Thursday, hitting $0.13. 1,706,289 shares of the company’s stock traded hands, compared to its average volume of 1,230,650. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.80 and a quick ratio of 2.80. Azitra has a 1-year low of $0.11 and a 1-year high of $4.33.

Azitra (NYSEAMERICAN:AZTRGet Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.15) earnings per share for the quarter. Azitra had a negative return on equity of 237.52% and a negative net margin of 1,644.90%.

About Azitra

(Get Free Report)

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.

Recommended Stories

Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.